1134749

Apellis Pharmaceuticals, Inc. — FEI 3016603289

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 13, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Waltham, MA (United States)

Additional Details

Sponsor, Contract Research Organization